CP as A Potential Drug Target (G1356)

Target Name: CP

NCBI ID: G1356

Content of Review Report on CP Target / Biomarker

CP as A Potential Drug Target

Ceruloplasmin (CP) is a protein that is expressed in a variety of tissues throughout the body, including the liver, spleen, and lungs. It is a member of the plasmin system, which is a group of enzymes that help to break down blood clots. In addition to its role in blood clotting, CP has also been shown to play a number of other important functions in the body, including helping to remove toxins from the liver and regulating the production of certain proteins.

One of the things that makes CP an interesting potential drug target is its unique structure. Unlike many other proteins, CP has a very stable and stable active site, which makes it difficult for drugs to interact with and inhibit its functions. This stability also makes it more resistant to degradation, which can help to ensure that it is expressed in the body and available for use as a drug.

In addition to its stable active site, CP also has a number of unique features that make it an attractive target for drugs. For example, it is a large protein that is expressed in high levels in many different tissues, which makes it difficult to target specifically. Additionally, its structure allows it to interact with a wide variety of molecules, which makes it versatile and able to be targeted by a range of different drugs.

One of the most promising aspects of CP as a drug target is its ability to interact with a wide variety of different molecules. This makes it possible that a drug that targets CP could be used to treat a wide range of different conditions. For example, studies have shown that drugs that target CP have been effective in treating a variety of different diseases, including cancer, liver disease, and autoimmune disorders.

In addition to its potential as a drug target, CP is also a potential biomarker. Its stability and resistance to degradation make it a good candidate for use as a protein biomarker, which could be used to diagnose and monitor certain diseases. For example, studies have shown that CP levels can be used as a marker for liver health, and that they can be affected by a variety of different factors, including alcohol consumption and infection with certain viruses.

Overall, Ceruloplasmin (CP) is an interesting protein that has a number of unique features that make it an attractive potential drug target. Its stable and stable active site, as well as its ability to interact with a wide variety of different molecules, make it a promising candidate for use as a drug. Additionally, its potential as a biomarker for certain diseases makes it an even more promising target for scientific research and development.

Protein Name: Ceruloplasmin

Functions: Ceruloplasmin is a blue, copper-binding (6-7 atoms per molecule) glycoprotein. It has ferroxidase activity oxidizing Fe(2+) to Fe(3+) without releasing radical oxygen species. It is involved in iron transport across the cell membrane. Provides Cu(2+) ions for the ascorbate-mediated deaminase degradation of the heparan sulfate chains of GPC1. May also play a role in fetal lung development or pulmonary antioxidant defense (By similarity)

The "CP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets